Virta

BLUE CROSS BLUE SHIELD OF MASSACHUSETTS EXPANDS ACCESS TO SPECIALTY CARE FOR MEMBERS

Retrieved on: 
Wednesday, October 11, 2023
Carbon, GI, Type 2 diabetes, Partnership, Social, MBA, Obesity, MD, Prediabetes, Blue Cross, Insurance, Health, Primary, Diabetes, Blue Cross Blue Shield Association, Face, Health insurance, Nursing, Virta, State, Oshi

BOSTON, Oct. 11, 2023 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts (Blue Cross) today announced that it is growing its network of virtual care providers to treat two chronic conditions: gastrointestinal (GI) conditions and diabetes. Oshi Health and Virta Health are now part of Blue Cross' network and, as part of their agreements with Blue Cross, offer convenient access to virtual care for members.

Key Points: 
  • Oshi Health and Virta Health are now part of Blue Cross' network and, as part of their agreements with Blue Cross, offer convenient access to virtual care for members.
  • "We understand the challenges members face accessing high-quality, affordable specialty care," said Lisa Glenn, Blue Cross' vice president of network partnerships and innovation.
  • We're excited to work with Blue Cross Blue Shield of Massachusetts to bring life-changing relief to its members who struggle with digestive health."
  • "Primary and specialty care play critical roles in members' overall care journeys, and it's our job to ensure our members have seamless access to both," said Dr. Ashley Yeats, Blue Cross' vice president of medical operations.

U-Haul, Quartz Health Solutions, and 70+ Other Major Payers Partner with Virta Health to Fight Back Against Obesity Epidemic

Retrieved on: 
Thursday, May 18, 2023
Insurance, Human Resources, Diabetes, Fitness & Nutrition, Clinical Trials, Professional Services, Health Insurance, General Health, Pharmaceutical, Health, Quartz, Linda, Injection, New England, Obesity, The New England Journal of Medicine, Stroke, Weight loss, Multimedia, Glucagon-like peptide-1 receptor agonist, Medicare, Bariatric surgery, Patient, Prediabetes, U-Haul, Pharmaceutical industry, Health care, Semaglutide, Virta

Type 2 diabetes reversal leader Virta Health reported substantial growth of its obesity solution over the last three years.

Key Points: 
  • Type 2 diabetes reversal leader Virta Health reported substantial growth of its obesity solution over the last three years.
  • View the full release here: https://www.businesswire.com/news/home/20230518005707/en/
    Major health plans and employers like U-Haul are partnering with Virta for both the clinical results and value-based payment model.
  • Currently, 20% of customers offer Virta’s weight loss solution, and 15% of Virta members are being treated specifically for obesity.
  • Classes of drugs like glucagon-like peptides (GLP-1s) are now being prescribed specifically for obesity, and show strong clinical promise.

Diabetes Reversal Leader Virta Health Earns Validation Institute’s Highest Ranking for Delivering Industry-Leading Prescription Drug Savings

Retrieved on: 
Monday, April 4, 2022
General Health, Diabetes, Other Health, Health, Pharmaceutical, Risk, Health, Conditional sentence, ROI, Leadership, Multimedia, HIV disease progression rates, Prediabetes, Certification, Patient, Validation, Cardiovascular disease, CEO, Prevalence, Weight loss, Third party, Technology, Diabetes, Twitter, Medicine, Inflammation, Insulin, Level 1, Physician, Solution, FDA, Risk management, Medical device, Pharmaceutical industry, Virta, General Health, Diabetes, Other Health, Health, Pharmaceutical

Virta Health, the leader in type 2 diabetes reversal, earned the Validation Institutes most prominent, Level 1 savings validation for delivering unmatched medication cost reductions.

Key Points: 
  • Virta Health, the leader in type 2 diabetes reversal, earned the Validation Institutes most prominent, Level 1 savings validation for delivering unmatched medication cost reductions.
  • Per the analysis, Virtas validated prescription drug savings amounted to nearly $6k per patient over a two-year period.
  • View the full release here: https://www.businesswire.com/news/home/20220331005756/en/
    As the only vendor in its category to achieve both a cost savings and a health outcomes validation, Validation Institute affirms Virta's leadership in delivering evidence-based clinical and financial performance.
  • "In a crowded marketplace, Virtas innovative diabetes reversal treatment stands out for its proven impact on health outcomes and for driving significant cost savings," said Benny DiCecca, CEO & President, Validation Institute.

Patients Receiving Virta’s Diabetes Reversal Treatment See Sustained Reduction in Depressive Symptoms, New Research Shows

Retrieved on: 
Wednesday, February 2, 2022
Diabetes, Pharmaceutical, Health, Mental Health, Insulin, Diagnosis, Risk, Patient, Diabetes, HIV disease progression rates, Insomnia, International Journal of Behavioral Medicine, Conditional sentence, A1C, Physician, American Diabetes Association, Clinical research, Twitter, Depression, Grammatical mood, Behavioral medicine, Type 2 diabetes, Technology, Research, ZF, Journal, CDC, Mental health, T2D, Health, Doctor of Philosophy, Self-management, Yeshiva University, FDA, Multimedia, Lists of Palestinian rocket attacks on Israel, PTSD, Associate, Weight loss, Pharmaceutical industry, Diabetes Care, Virta

Virta Health , the leader in type 2 diabetes reversal, announced promising results on the impact of its diabetes reversal treatment on depressive symptoms.

Key Points: 
  • Virta Health , the leader in type 2 diabetes reversal, announced promising results on the impact of its diabetes reversal treatment on depressive symptoms.
  • The research, published in The Journal of Behavioral Medicine , highlights rapid and sustained improvement in depressive symptoms during treatment, with nearly one-third fewer patients meeting the clinical cutoff for depression at two years.
  • View the full release here: https://www.businesswire.com/news/home/20220202005670/en/
    According to Virtas latest research, patients receiving its diabetes reversal treatment improved both depressive symptoms and metabolic health simultaneously.
  • According to research published in Diabetes Care , patients with T2D that are experiencing depressive symptoms are much less likely to adhere to diabetes treatment recommendations, leading to worse outcomes.

CerpassRx Announces Integrated Partnership with Virta Health

Retrieved on: 
Tuesday, August 3, 2021
Virta, Virta, Pharmacy benefit management

DALLAS, Aug. 3, 2021 /PRNewswire/ --Today, CerpassRx, a Texas-based pharmacy benefit management company, announced the launch of its integrated partnership with diabetes reversal leader Virta Health .

Key Points: 
  • DALLAS, Aug. 3, 2021 /PRNewswire/ --Today, CerpassRx, a Texas-based pharmacy benefit management company, announced the launch of its integrated partnership with diabetes reversal leader Virta Health .
  • Through this partnership, Virta will be available to members and eligible dependents who have pharmacy benefits through CerpassRx and are between the ages of 18 and 79.
  • "CerpassRx has long been a leader in connecting its members with innovative healthcare solutions like Virta," said Trent Myers, VP of Commercial at Virta.
  • Through this dynamic partnership, CerpassRx and Virta Health will be able to transform member's lives by reversing type 2 diabetes, while also lowering healthcare costs and placing all program fees 100% at risk.

Diabetes Reversal Leader Virta Health Raises $133M Series E to Take Type 2 Diabetes Reversal Mainstream

Retrieved on: 
Monday, April 19, 2021
General Health, Diabetes, Health, Pharmaceutical, Clinical trials, Articles, Health, Diabetes, Virta Health, Telehealth, Type 2 diabetes, Virta

b'Virta Health , the leader in type 2 diabetes reversal, today announced $133 million of equity financing led by Tiger Global .

Key Points: 
  • b'Virta Health , the leader in type 2 diabetes reversal, today announced $133 million of equity financing led by Tiger Global .
  • View the full release here: https://www.businesswire.com/news/home/20210419005560/en/\nThe latest funding round will accelerate Virta\'s efforts to drive widespread adoption of its telehealth-powered diabetes reversal treatment.
  • (Graphic: Business Wire)\nBuoyed by delivering transformational outcomes in patient health and cost savings, Virta is experiencing surging demand from large employers, health plans, and government entities.
  • Virta reverses type 2 diabetes through innovations in technology, nutrition science, and continuous remote care from physicians and behavioral experts.

Diabetes Reversal Leader Virta Health Appoints Chief Financial Officer

Retrieved on: 
Wednesday, February 3, 2021
General Health, Diabetes, Health, Fitness & Nutrition, Pharmaceutical, Virta Health, Virta

Virta Health , the type 2 diabetes reversal leader, today announced the appointment of Alok Bhushan to Chief Financial Officer.

Key Points: 
  • Virta Health , the type 2 diabetes reversal leader, today announced the appointment of Alok Bhushan to Chief Financial Officer.
  • In 2020, Virta experienced record growth and now counts more than 100 large payers from health plans, major enterprises, and all parts of government as customers.
  • Together with Bhushans hire, Virta looks to capitalize on this momentum and bring metabolic disease reversal to the masses.
  • Virta works with the largest health plans, employers, and government organizations and puts 100% of its fees at risk based on clinical and financial outcomes.

Virta Health Partners With St. Louis Area Business Health Coalition to Expand Access to Type 2 Diabetes Reversal Treatment

Retrieved on: 
Wednesday, August 26, 2020
Biotechnology, Diabetes, Health, Virta, Wellness

Virta has already demonstrated success in treating patients from BHC member companies, including Deann McMorris, an employee of Bass Pro Shops.

Key Points: 
  • Virta has already demonstrated success in treating patients from BHC member companies, including Deann McMorris, an employee of Bass Pro Shops.
  • With the guidance of my Virta team, I lost 18 pounds in less than a month after starting the treatment.
  • Virta delivers unheard-of outcomes in diabetes treatment, said Sara Correnti, Manager, Health and Welfare Member Wellness Products, at Concordia Plan Services.
  • About St. Louis Area Business Health Coalition:
    The St. Louis Area Business Health Coalition (BHC) is a non-profit organization representing over 70 leading employers, which provide health benefits to thousands of lives in Missouri and millions nationally.

Virta Health Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance

Retrieved on: 
Wednesday, April 15, 2020
Diabetes, Security, Health, Practice Management, Technology, HITRUST, Regulatory compliance, Virta, Professional certification

This achievement places Virta Health in an elite group of organizations worldwide that have earned this certification.

Key Points: 
  • This achievement places Virta Health in an elite group of organizations worldwide that have earned this certification.
  • HITRUST is continually innovating to help streamline and simplify how organizations assess information risk and manage compliance in a cloud environment, said Jeremy Huval, Chief Compliance Officer, HITRUST.
  • We are happy that Virta Health has taken the steps needed to achieve HITRUST CSF Certificationa designation which provides added confidence to their customers.
  • Virta Health, which works with health plans and large enterprises across the United States, also recently received its SOC-2 Type 1 certification.

Virta Health Partners with U.S. Department of Veterans Affairs to Help Veterans with Type 2 Diabetes

Retrieved on: 
Thursday, May 16, 2019
Other Consumer, Health, Alternative medicine, Cardiology, Clinical trials, Diabetes, Consumer, Organ systems, Diabetes, RTT, Aftermath of war, Diabetes mellitus, Medicine, Clinical medicine, Veteran, Virta

Virta Health , the first company to safely and sustainably reverse type 2 diabetes without medications or surgery, today announced an innovative partnership with the Department of Veterans Affairs (VA) to provide new hope for Veterans living with type 2 diabetes.

Key Points: 
  • Virta Health , the first company to safely and sustainably reverse type 2 diabetes without medications or surgery, today announced an innovative partnership with the Department of Veterans Affairs (VA) to provide new hope for Veterans living with type 2 diabetes.
  • This pilot program offers 400 Veterans access to the Virta Treatment, with the goal of helping Veterans improve metabolic health while simultaneously reducing dependency on diabetes medications.
  • This partnership underscores VAs commitment to pursuing creative approaches that can make transformational improvements in Veterans health, said Sami Inkinen, Virta Health co-founder and CEO.
  • Virta Health provides the first treatment to safely and sustainably reverse type 2 diabetes without medications or surgery.